Triethylamine hydrochloride → 6-Chloro-3-(2,6-difluorophenyl)-7-(1,1-dimethylethyl)-1,2,4-triazolo[4,3-b]pyridazine

HRID 2301337

Reaktionsgleichung

Reaktionsgleichung von HRID 2301337
[Cl:1][C:2]1[N:3]=[N:4][C:5](Cl)=[CH:6][C:7]=1[C:8]([CH3:11])([CH3:10])[CH3:9].[F:13][C:14]1[CH:23]=[CH:22][CH:21]=[C:20]([F:24])[C:15]=1[C:16]([NH:18][NH2:19])=O.Cl.C(N(CC)CC)C>O1CCOCC1>[Cl:1][C:2]1[C:7]([C:8]([CH3:11])([CH3:10])[CH3:9])=[CH:6][C:5]2[N:4]([C:16]([C:15]3[C:20]([F:24])=[CH:21][CH:22]=[CH:23][C:14]=3[F:13])=[N:18][N:19]=2)[N:3]=1

Komponenten

5

Versuchsvorschrift

A mixture of 3,6-dichloro-4-(1,1-dimethylethyl)pyridazine (2 g, 9.75 mmol), 2,6-difluorobenzoic acid hydrazide (2.52 g, 14.6 mmol) (WO 95/24403) and triethylamine hydrochloride (2.01 g, 14.6 mmol) in 1,4-dioxane (10 ml) was stirred and heated at reflux for 3.5 days. Upon cooling, the volatiles were removed in vacuo and the residue was triturated with dichloromethane. Any undissolved solid was removed by filtration. The residue was purified by chromatography on silica gel eluting with 0%→25% ethyl acetate in dichloromethane to give the required product (0.42 g). Data for the title compound: 1H NMR (250 MHz, CDCl3) δ1.57 (9H, s), 7.09-7.16 (2H, m), 7.51-7.63 (1H, m), 8.19 (1H, s); MS (ES30) m/e 323 (MH+.

Aufarbeitung

  1. temperatureheated
  2. temperatureat reflux for 3.5 days
  3. temperatureUpon cooling
  4. customthe volatiles were removed in vacuo
  5. customthe residue was triturated with dichloromethane
  6. customAny undissolved solid was removed by filtration
  7. customThe residue was purified by chromatography on silica gel eluting with 0%→25% ethyl acetate in dichloromethane

Quellen und Nachweise

ORD-Eintrag
ord-34c2f76c0c3849799ce74e5dab82164e
Quelldatensatz
uspto-grants-2002_12
Patentnummer
US06500828B1

Verknüpfte Notizen

Wird geladen…